{"id":331918,"date":"2026-10-29T12:46:37","date_gmt":"2026-10-29T07:16:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/lincoln-pharmaceuticals-q2-results-fy27-pat-20-crore\/"},"modified":"2026-10-29T12:46:37","modified_gmt":"2026-10-29T07:16:37","slug":"lincoln-pharmaceuticals-q2-results-fy27-pat-20-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/lincoln-pharmaceuticals-q2-results-fy27-pat-20-crore\/","title":{"rendered":"Lincoln Pharmaceuticals Q2 Results FY27: Revenue Up 17.13% to Rs 191.35 Cr, PAT Rs 20.43 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Lincoln Pharmaceuticals Q2 Results FY27 were declared on 29 October 2026 on a Consolidated basis. Revenue rose 17.13% YoY to Rs 191.35 Cr, while net profit increased 2.25% YoY to Rs 20.43 Cr. These quarterly results show YoY growth in revenue, whereas Operating Profit declined 6.84% YoY to Rs 23.69 Cr.<\/p>\n<\/div>\n

Lincoln Pharmaceuticals Ltd<\/a> (LINCOLN) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brings consolidated results with revenue of Rs 191.35 Cr against Rs 163.36 Cr a year earlier and net profit (PAT) of Rs 20.43 Cr against Rs 19.98 Cr. Lincoln Pharmaceuticals Q2 Results FY27 also show Operating Profit of Rs 23.69 Cr, down from Rs 25.43 Cr.<\/p>\n

This results analysis of Lincoln Pharmaceuticals Q2 Results covers the financial highlights, business drivers, outlook and risks, with Univest data used throughout. The Financial Highlights table below sets out every metric against the same quarter last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n